Future MINDDS: Recent advances and future directions for research of Neurodevelopmental Disorders (NDD) associated with pathogenic CNV (Copy Number Variants).
Rare neurodevelopmental disorders and copy number variants: The facts and knowledge gaps. This is a one day workshop that is targeted at health care professionals. It is for anyone who wants to increase their knowledge of copy number variants associated with adverse neurodevelopmental and neuropsychiatric outcomes.
MINDDS 2 is a workshop offered by the MINDDS COST Action to focus on research for patients, who have Neurodevelopmental Disorders (NDD) arising from possession of pathogenic Copy Number Variants (CNV) of high genetic penetrance.
Stem cell methods and cell phenotyping approaches for study of neurodevelopmental disorders.
The Brussels meeting discussed in detail the first steps to achieve the short-term goals of WG1, WG2 and WG4.
MINDDS COST Action held its first workshop from 5th to 6th of March 2018, in Belgrade, the capital of Serbia, in the heart of Europe.
July 3rd 2019 WG2 Clinical phenotyping task-oriented workshop in Vienna
MINDDS is a pan-European network of researchers, clinicians and patient organizations, who aim to facilitate research activity on neurodevelopmental disorders (NDD) associated with rare Copy Number Variants (CNV).
MINDDS 3 is a workshop offered by the MINDDS COST Action to focus on research for patients, who have Neurodevelopmental Disorders (NDD) arising from possession of pathogenic Copy Number Variants (CNV) of high genetic penetrance.
Working Group 1 (WG1) Leader and Management Committee member of COST Action 16210 – Maximizing Impact of Research in Neurodevelopmental Disorders (MINDDS), Natália Oliva Teles and Paula Jorge respectively, would like to organize a Workshop for CA16210 members at partners, in Porto, Portugal.
CONVERGENT MINDDS: Convergence Neuroscience for Neurodevelopmental Disorders (NDD). The MINDDS COST Action is organising a Workshop to discuss a Convergence Neuroscience approach the study of NDD.